By Sindy Von Bank, Director of Strategic Partnerships, Healthcare Division of Connect America | February 23, 2021
Cardiovascular disease is the number one cause of death in the U.S. and a significant cause of disability, limiting the activity and quality of life for millions of individuals.1, According to research published in the Journal of the American Medical Association, cardiovascular disease is on the rise with nearly half of all adults in the United States living with some form of the disease. Equally concerning is that an estimated 80% of cardiovascular disease is preventable through controlling high blood pressure, diabetes and cholesterol and adopting healthy lifestyle behaviors. Still, cardiovascular disease remains the No. 1 killer and the most expensive disease, costing nearly $1 billion a day.2
Given the growing numbers and escalating costs, it is no surprise that demand for remote patient monitoring (RPM) has been rapidly increasing within the field of cardiology. The volume of patients with cardiovascular disease has been steadily rising and delivering quality care to this growing population can be challenging, even for the most efficient providers.3
RPM technology enables clinicians to remotely observe the progression of their patients’ condition through medical devices that monitor the patient’s vital signs from their home. The technology gives providers a more comprehensive view of a patient’s health over time, increasing visibility into patient adherence and allowing for timely intervention before a costly care episode.
Evidence suggests that RPM lowers the risk of heart failure hospital admissions and mortality. It has also been shown to help predict potential issues earlier and improve the quality of life for CHD patients.4 According to the American Heart Association, guidelines recommend the use of RPM for atrial fibrillation (AF) detection in both stroke and non-stroke patients. It has also been shown to help reduce systolic blood pressure and diastolic blood pressure significantly compared to standard care.4 The American Heart Association strongly supports the use of RPM technologies for better cardiovascular disease outcomes, including for hypertension, heart failure and arrhythmias.4
Not only has RPM been shown to help deliver better cardiovascular outcomes, but it reduces barriers to care, such as transportation, location, and difficulty getting to and from appointments due to climate challenges. In addition, RPM has been used to effectively help lower the risk of potential exposure to COVID-19 for patients and medical staff.
Overall, RPM is a proven and valuable tool in assisting clinicians in making more informed decisions that improve health outcomes while increasing engagement and accountability, specifically in patients with chronic conditions such as cardiovascular disease.